Pollen Maddox Limited 31/03/2026 iXBRL

Company registration number: 15724085

Pollen Maddox Limited

Unaudited filleted financial statements

31 March 2026

Pollen Maddox Limited

Contents

Directors and other information

Statement of financial position

Statement of changes in equity

Notes to the financial statements

Pollen Maddox Limited

Directors and other information


	Directors	Mr Christopher James Wilkes
		Mr Michael Fitzgerald


	Company number	15724085


	Registered office	124-128 City Road
		London
		EC1V 2NX

Pollen Maddox Limited

Statement of financial position

31 March 2026


	Note	£	£	£	£

Fixed assets
Tangible assets	5	12,117		6,145
		_______		_______
			12,117		6,145

Current assets
Debtors	6	325,704		91,054
Cash at bank and in hand		162,921		119,612
		_______		_______
		488,625		210,666
Creditors: amounts falling due
within one year	7	( 268,616)		( 118,243)
		_______		_______
Net current assets			220,009		92,423
			_______		_______
Total assets less current liabilities			232,126		98,568

			_______		_______
Net assets			232,126		98,568
			_______		_______

Capital and reserves
Called up share capital			90		90
Profit and loss account			232,036		98,478
			_______		_______
Shareholders funds			232,126		98,568
			_______		_______

For the year ending 31 March 2026 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Directors responsibilities:

- The members have not required the company to obtain an audit of its financial statements for the year in question in accordance with section 476;

- The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of financial statements.

These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies' regime and in accordance with Section 1A of FRS 102 'The Financial Reporting Standard applicable in the UK and Republic of Ireland'.

In accordance with section 444 of the Companies Act 2006, the statement of comprehensive income has not been delivered.

These financial statements were approved by the board of directors and authorised for issue on 19 June 2026 , and are signed on behalf of the board by:

Mr Christopher James Wilkes

Director

Company registration number: 15724085

Pollen Maddox Limited

Statement of changes in equity

Year ended 31 March 2026

	Called up share capital	Profit and loss account	Total
	£	£	£


At 1 April 2024	-	-	-

Profit for the year		119,478	119,478
	_______	_______	_______
Total comprehensive income for the year	-	119,478	119,478

Issue of shares	90		90
Dividends paid and payable		( 21,000)	( 21,000)
	_______	_______	_______
Total investments by and distributions to owners	90	( 21,000)	( 20,910)

	_______	_______	_______
At 31 March 2025 and 1 April 2025	90	98,478	98,568

Profit for the year		400,868	400,868
	_______	_______	_______
Total comprehensive income for the year	-	400,868	400,868

Dividends paid and payable		( 267,310)	( 267,310)
	_______	_______	_______
Total investments by and distributions to owners	-	( 267,310)	( 267,310)

	_______	_______	_______
At 31 March 2026	90	232,036	232,126
	_______	_______	_______

Pollen Maddox Limited

Notes to the financial statements

Year ended 31 March 2026

1. General information

The company is a private company limited by shares, registered in England and Wales. The address of the registered office is 124-128 City Road, London, EC1V 2NX.

The company incorporated on 16 May 2024.

2. Statement of compliance

These financial statements have been prepared in compliance with the provisions of FRS 102, Section 1A, 'The Financial Reporting Standard applicable in the UK and Republic of Ireland'.

3. Accounting policies

Basis of preparation

The financial statements have been prepared on the historical cost basis.

The financial statements are prepared in sterling, which is the functional currency of the entity.

Turnover

Turnover is measured at the fair value of the consideration received or receivable for services rendered, net of discounts and Value Added Tax.

Revenue from the rendering of services is measured by reference to the stage of completion of the service transaction at the end of the reporting period provided that the outcome can be reliably estimated. When the outcome cannot be reliably estimated, revenue is recognised only to the extent that expenses recognised are recoverable.

Taxation

The taxation expense represents the aggregate amount of current and deferred tax recognised in the reporting period. Tax is recognised in the statement of comprehensive income, except to the extent that it relates to items recognised in other comprehensive income or directly in capital and reserves. In this case, tax is recognised in other comprehensive income or directly in capital and reserves, respectively. Current tax is recognised on taxable profit for the current and past periods. Current tax is measured at the amounts of tax expected to pay or recover using the tax rates and laws that have been enacted or substantively enacted at the reporting date.

No provision for deferred taxation has been provided for in the financial statements, due to the amount not being material.

Operating leases

Lease payments are recognised as an expense over the lease term on a straight-line basis. The aggregate benefit of lease incentives is recognised as a reduction to expense over the lease term, on a straight-line basis.

Tangible assets

tangible assets are initially recorded at cost, and are subsequently stated at cost less any accumulated depreciation and impairment losses.

Depreciation

Depreciation is calculated so as to write off the cost or valuation of an asset, less its residual value, over the useful economic life of that asset as follows:



Fittings fixtures and equipment	-	25%	reducing balance

If there is an indication that there has been a significant change in depreciation rate, useful life or residual value of tangible assets, the depreciation is revised prospectively to reflect the new estimates.

Impairment

A review for indicators of impairment is carried out at each reporting date, with the recoverable amount being estimated where such indicators exist. Where the carrying value exceeds the recoverable amount, the asset is impaired accordingly. Prior impairments are also reviewed for possible reversal at each reporting date.

Financial instruments

A financial asset or a financial liability is recognised only when the company becomes a party to the contractual provisions of the instrument.

Basic financial instruments are initially recognised at the transaction price, unless the arrangement constitutes a financing transaction, where it is recognised at the present value of the future payments discounted at a market rate of interest for a similar debt instrument.

Debt instruments are subsequently measured at amortised cost.

Financial assets that are measured at cost or amortised cost are reviewed for objective evidence of impairment at the end of each reporting date. If there is objective evidence of impairment, an impairment loss is recognised in profit or loss immediately. For all equity instruments regardless of significance, and other financial assets that are individually significant, these are assessed individually for impairment. Other financial assets are either assessed individually or grouped on the basis of similar credit risk characteristics. Any reversals of impairment are recognised in profit or loss immediately, to the extent that the reversal does not result in a carrying amount of the financial asset that exceeds what the carrying amount would have been had the impairment not previously been recognised.

Defined contribution plans

Contributions to defined contribution plans are recognised as an expense in the period in which the related service is provided. Prepaid contributions are recognised as an asset to the extent that the prepayment will lead to a reduction in future payments or a cash refund. When contributions are not expected to be settled wholly within 12 months of the end of the reporting date in which the employees render the related service, the liability is measured on a discounted present value basis. The unwinding of the discount is recognised in finance costs in profit or loss in the period in which it arises.

4. Employee numbers

The average number of persons employed by the company during the year amounted to 4 (2025: 2 ).

5. Tangible assets

	Fixtures, fittings and equipment	Total
	£	£
Cost
At 1 April 2025	6,590	6,590
Additions	8,099	8,099
	_______	_______
At 31 March 2026	14,689	14,689
	_______	_______
Depreciation
At 1 April 2025	445	445
Charge for the year	2,127	2,127
	_______	_______
At 31 March 2026	2,572	2,572
	_______	_______
Carrying amount
At 31 March 2026	12,117	12,117
	_______	_______
At 31 March 2025	6,145	6,145
	_______	_______

6. Debtors


	£	£
Trade debtors	325,614	90,964
Other debtors	90	90
	_______	_______
	325,704	91,054
	_______	_______

7. Creditors: amounts falling due within one year


	£	£
Trade creditors	6,550	200
Corporation tax	135,806	38,753
Social security and other taxes	105,368	50,696
Other creditors	20,892	28,594
	_______	_______
	268,616	118,243
	_______	_______

8. Directors advances, credits and guarantees

	During the year the directors entered into the following advances and credits with the company:

Year ended
		Balance brought forward	Advances /(credits) to the directors	Balance o/standing
		£	£	£
	Mr Christopher James Wilkes	( 2,000)	2,000	-
		_______	_______	_______

Period Ended
		Balance brought forward	Advances /(credits) to the directors	Balance o/standing
		£	£	£
	Mr Christopher James Wilkes	-	( 2,000)	( 2,000)
		_______	_______	_______